The expression of insulin-like growth factor- I mRNA and polypeptide in rat osteoblasts with exposure to parathyroid hormone

Chinese Medical Journal

Volumn 116, Issue 12, 2003, Pages 1916-1922

  Zhang, Keqin ^a   Chen, Jiawei ^a   Wang, Meilian ^a   Wang, Chengya ^a   Li, Guangfu ^a   Zheng, Zhaoxi ^a   Zhao, Renzheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cytology; Insulin like growth factor I; Osteoblast; Osteoporosis; Parathyroid hormone

Indexed keywords

ALKALINE PHOSPHATASE; MESSENGER RNA; PARATHYROID HORMONE; POLYPEPTIDE; PROTEIN ANTIBODY; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL COMMUNICATION; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EXPOSURE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE ACTION; INCUBATION TIME; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHARMACOKINETICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR I; OSTEOBLASTS; PARATHYROID HORMONE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0742306361     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Morley P, Whitfield JF, Willick GE. Anabolic effects of parathyroid hormone on bone. Trends Endocrinol Metab 1997;8:225-231.
2. Rosen CJ, Bilezikian JP. Hot topic: Anabolic therapy for osteoporosis. J Clin Endocrinol Metab 2001;86:957-964.
3. Ebeling PR, Jones JD, O'Fallon WM, et al. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 1993;77:1384-1387.
4. Ghiron LJ, Thompson JL, Holloway L, et al. Effects of recombinant insulin-like growth factor I and growth hormone on bone turnover in elderly women. J Bone Miner Res 1995; 10:1844-1852.
5. Schmid C, Schläpeer I, Peter M, et al. Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. Am J Physiol 1994;E226-E233.
6. McCarthy TL, Centrella M, Canalis E. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1989;124:1247-1253.
7. Linkhart T, Mohan S. Parathyroid hormone stimulates releases of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 1989;125:1484-1491.
8. Canalis E, Centrella M, Burch W, et al. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone culture. J Clin Invest 1989;83:60-65.
9. Dobnig H, Turner RT. The effects of programmed administration of human parathyroid hormone on bone histomorphometry and serum chemistry in rats. Endocrinology 1997;138:4607-4612.
10. Lindsay R, Nieves J, Henneman E, et al. Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone (1-34): kinetics and biochemical response in estrogenized osteoporotic patients. J Clin Endocrinol Metab 1993;77:1535-1539.
11. Schwietert HR, Groen EW, Sollie FA, et al. Single-dose subcutaneous administration of recombinant human parathyroid hormone [ rhPTH (1-84) ] in healthy postmenopausal volunteers. Clin Pharmacol Ther 1997;61: 360-376.
12. Watson PH, Lazowski D, Han V, et al. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 1995; 16:357-365.
13. Watson PH, Fraher LJ, Kisiel M, et al. Enhanced osteoblast development after continuous infusion of hPTH (1-84) in the rat. Bone 1999;24:89-94.
14. Bodine PVN, Henderson RA, Green J, et al. Estrogen receptor-a is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 1998;139:2048-2057.
15. Genovese C, Rowe D, Kream B. Construction of DNA sequences complementary to rat a1 and a2 collagen mRNA and their use in studing the regulation of type I collagen synthesis by 1, 25-dihydroxyvitamin D. Biochemistry 1984; 23:6210-6216.
16. Sussenbach JS. The gene structure of the insulin-like growth factor family. Prog Growth Factor Res 1989;1:33-48.
17. McSheehy PMJ, Chambers TJ. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 1986;118:824-828.
18. Carmichael J, DeGraff WG, Gazdar AF, et al. Evalution of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47: 936-942.
19. Winn SR, Randolph G, Uludag H, et al. Establishing an immortalized human osteoprecursor cell line OPC1. J Bone Miner Res 1999;14:1721-1733.
20. Ishizuya T, Yokose S, Hori M, et al. Parathyroid hormone exerts disparate effects on osteoblast differentiation on exposure time in rat osteoblastic cells. J Clin Invest 1997:99: 2961-2970.
21. Nacher M, Serrano S, Marinoso ML, et al. In vitro synthesis of type I collagen: quantification of carboxyterminal propeptide of procollagen type I versus tritiated proline incorporation. Calcif Tissue Int 1999;64:224-228.
22. Kudo Y, Iwashita M, Iguchi T, et al. Estrogen and parathyroid hormone regulate insulin-like growth factor binding protein-4 in SaOS-2 cells. Life Sci 1997;61:165-170.